• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection

tetano

Editor, Senior Moderator
Front Immunol


. 2021 Dec 9;12:747654.
doi: 10.3389/fimmu.2021.747654. eCollection 2021.
Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection


Praveen M Varghese[SUP] 1 2 [/SUP], Shuvechha Mukherjee[SUP] 3 [/SUP], Futwan A Al-Mohanna[SUP] 4 [/SUP], Souad M Saleh[SUP] 4 [/SUP], Fahad N Almajhdi[SUP] 5 [/SUP], Nazar Beirag[SUP] 1 [/SUP], Saad H Alkahtani[SUP] 6 [/SUP], Reena Rajkumari[SUP] 2 [/SUP], Beatrice Nal Rogier[SUP] 7 [/SUP], Robert B Sim[SUP] 8 [/SUP], Susan Idicula-Thomas[SUP] 3 [/SUP], Taruna Madan[SUP] 9 [/SUP], Valarmathy Murugaiah[SUP] 1 [/SUP], Uday Kishore[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

The complement system is designed to recognise and eliminate invading pathogens via activation of classical, alternative and lectin pathways. Human properdin stabilises the alternative pathway C3 convertase, resulting in an amplification loop that leads to the formation of C5 convertase, thereby acting as a positive regulator of the alternative pathway. It has been noted that human properdin on its own can operate as a pattern recognition receptor and exert immune functions outside its involvement in complement activation. Properdin can bind directly to microbial targets via DNA, sulfatides and glycosaminoglycans, apoptotic cells, nanoparticles, and well-known viral virulence factors. This study was aimed at investigating the complement-independent role of properdin against Influenza A virus infection. As one of the first immune cells to arrive at the site of IAV infection, we show here that IAV challenged neutrophils released properdin in a time-dependent manner. Properdin was found to directly interact with haemagglutinin, neuraminidase and matrix 1 protein Influenza A virus proteins in ELISA and western blot. Furthermore, modelling studies revealed that properdin could bind HA and NA of the H1N1 subtype with higher affinity compared to that of H3N2 due to the presence of an HA cleavage site in H1N1. In an infection assay using A549 cells, properdin suppressed viral replication in pH1N1 subtype while promoting replication of H3N2 subtype, as revealed by qPCR analysis of M1 transcripts. Properdin treatment triggered an anti-inflammatory response in H1N1-challenged A549 cells and a pro-inflammatory response in H3N2-infected cells, as evident from differential mRNA expression of TNF-α, NF-κB, IFN-α, IFN-β, IL-6, IL-12 and RANTES. Properdin treatment also reduced luciferase reporter activity in MDCK cells transduced with H1N1 pseudotyped lentiviral particles; however, it was increased in the case of pseudotyped H3N2 particles. Collectively, we conclude that infiltrating neutrophils at the site of IAV infection can release properdin, which then acts as an entry inhibitor for pandemic H1N1 subtype while suppressing viral replication and inducing an anti-inflammatory response. H3N2 subtype can escape this immune restriction due to altered haemagglutinin and neuraminindase, leading to enhanced viral entry, replication and pro-inflammatory response. Thus, depending on the subtype, properdin can either limit or aggravate IAV infection in the host.

Keywords: RNA viruses; complement evasion; complement system; cytokine storm; human properdin; influenza A virus; innate immune system.
 
Back
Top Bottom